共 50 条
- [41] Impact of GLP-1 Agonist Use on Non-Alcoholic Fatty Liver Disease Among Patients at a Large, Tertiary Care Center AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S610 - S610
- [42] Subanalysis of Teduglutide Efficacy and Safety Data from Patients with Crohn's Disease and Ulcerative Colitis in the STEPS Study AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 : S265 - S265
- [43] Clinical Presentation and Outcomes of Patients With Mid-Small Bowel Crohn's Disease From a Large Referral Center Cohort AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S366 - S366
- [45] Burden of Herpes Zoster Among Patients With Ulcerative Colitis and Crohn's Disease in the United States: A Retrospective Cohort Study Using a Large Administrative Claims Database AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S419 - S420
- [46] Risk of Inflammatory Bowel Disease Complications in Obese Inflammatory Bowel Disease Patients on GLP-1 Therapy: A Large Multicenter Cohort Study AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S1056 - S1057
- [47] No association of alcohol use and the risk of ulcerative colitis or Crohn’s disease: data from a European Prospective cohort study (EPIC) European Journal of Clinical Nutrition, 2017, 71 : 512 - 518
- [48] A real-world study of outcomes in biologic-naive patients with Crohn's disease and ulcerative colitis initiating vedolizumab JOURNAL OF CROHNS & COLITIS, 2016, 10 : S238 - S238
- [50] Outcomes and healthcare utilization. in a population-based inception cohort of pediatric Crohn's disease and ulcerative colitis patients in Brittany, France PEDIATRIC GASTROENTEROLOGY 2004, 2004, : 529 - 532